Document Type : short communication


Shiraz University of Medical Science, Shiraz, Iran.


Background: Beta thalassemia intermedia is a group of anemias that are in the middle of the symptoms of beta thalassemia minor and major. Disturbance in the balance of alpha and beta chains causes different symptoms in patients. At one end of the spectrum are patients with mild symptoms, and at the other end the patients who may become dependent on blood transfusion, with difficulties deciding which patient needs blood transfusion and when. This challenge is more significant during pregnancy because blood transfusion at the wrong time and not transfusing when needed can cause complications in both mother and fetus.
Methods: In this one-year study, a total of 8 pregnant patients with intermedia thalassemia were studied, and according to the Australian guideline, patients with  were not given blood unless they suffered from PHT, massive splenomegaly, IUGR; but patients with   were transfused.
Results: Finally, the pregnancy outcome was compared in terms of birth weight and Apgar score; and there was no significant difference.
Conclusion: Hb level 7 during pregnancy can be considered safe for preventing unnecessary blood transfusion and their complications. This study can be the onset of a wider study in this field to help gynecologists for patient management.


  1. Greer JP, Arber DA, Glader BE, List AF, Means RM, Rodgers GM. Wintrobe's clinical hematology: Lippincott Williams & Wilkins; 2018.
  2. Weatherall DJ, Clegg JB. The thalassaemia syndromes: John Wiley & Sons; 2008.
  3. No G-tG. Management of beta thalassaemia in pregnancy. 2014.
  4. Abdolalian M, Ebrahimi M, Aghamirzadeh M, Eshraghi N, Moghaddasi M, Eslamnik P. The role of leukemia inhibitory factor in pathogenesis of pre-eclampsia: molecular and cell signaling approach. Journal of Molecular Histology. 2021; 52(4):635-42.
  5. Abdallah AM. Thalassemia and pregnancy complications. World Journal of Advanced Research and Reviews. 2022; 14(1):363-7.
  6. Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F, Lucchini MJ, Machin J, Nimubona S, Ribeil JA, Galacteros F, Cannas G, Hot A. Pregnancy outcome in women with transfused beta-thalassemia in France. Annals of Hematology. 2022; 101(2):289-96.
  7. Halim-Fikri BH, Lederer CW, Baig AA, Assyuhada Mat-Ghani NS, Rahayu-Karmilla Syed-Hassan SN, Yusof W, Rashid DA, Azman NF, Fucharoen S, Panigoro R, Silao CLT, Viprakasit V, Jalil N, Yasin NM, Bahar R, Selvaratnam V, Mohamad N, Nik Hassan NN, Esa E, Krause A, Robinson H, Hasler J, Stephanou C, Raja-Sabudin RZA, Elion J, El-Kamah G, Coviello D, Yusoff N, Latiff ZA, Arnold C, Burn J, Kountouris P, Kleanthous M, Ramesar R, Zilfalil BA, On Behalf Of The Global Globin Network Ggn. Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries. Journal of personalized medicine. 2022; 12(4):552.
  8. Petrakos G, Andriopoulos P, Tsironi M. Pregnancy in women with thalassemia: challenges and solutions. International journal of women's health. 2016; 8:441.
  9. Rajagopalan KS, Kazeminia S, Glasstetter LM, Farahani RA, Zhu X-Y, Tang H, Jordan KL, Chade AR, Lerman A, Lerman LO, Eirin A. Metabolic Syndrome Induces Epigenetic Alterations in Mitochondria-Related Genes in Swine Mesenchymal Stem Cells. Cells. 2023; 12(9):1274.
  10. Shahverdi E, Moghaddam M, Gorzin F. Maternal red blood cell alloantibodies identified in blood samples obtained from Iranian pregnant women: the first population study in Iran. Transfusion. 2017; 57(1):97-101.
  11. Zdanowicz JA, Surbek D. Patient blood management in obstetrics–Review. Transfusion and apheresis science. 2019; 58(4):412-5.
  12. Hosseini H, Far MJ, Saki N, Galehdari H, Saki A. Study of beta-globin chain mutations in patients with beta thalassemia trait among different racial groups in Khouzestan Province. Genetics in the 3rd millennium. 2013; 10(4):2868-73.
  13. Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. Bmj. 2006; 333(7573):831-4.
  14. Tadmouri GO, Al Ali MT, Al-Haj Ali S, Al Khaja N. CTGA: the database for genetic disorders in Arab populations. Nucleic Acids Res. 2006; 34(Database issue):D602-6.
  15. Genetic services in Europe. A comparative study of 31 countries by the Concerted Action on Genetic Services in Europe. Eur J Hum Genet. 1997; 5 Suppl 2:1-220.
  16. Pouranfard J, Vafaei F, Afrouz S, Rezaeian M. Thalassemia gene mutations in Kohgiluyeh and Boyer-Ahmad province. Iranian Journal of Blood and Cancer. 2020; 12(1):18-23.
  17. Farashi S, Bayat N, Faramarzi Garous N, Ashki M, Montajabi Niat M, Vakili S, Imanian H, Zeinali S, Najmabadi H, Azarkeivan A. Interaction of an α-globin gene triplication with β-globin gene mutations in Iranian patients with β-thalassemia intermedia. Hemoglobin. 2015; 39(3):201-6.
  18. Akbari E, Sarbazi F, Karimi A, Nouri B, Ardebili SN. Comparison of Laparoscopic Myomectomy Outcomes Based on Myoma Weight: A Cross-sectional Study. International Journal of Women's Health & Reproduction Sciences. 2022; 10(1).
  19. Ho P, Tay L, Lindeman R, Catley L, Bowden D. Australian guidelines for the assessment of iron overload and iron chelation in transfusion‐dependent thalassaemia major, sickle cell disease and other congenital anaemias. Internal medicine journal. 2011; 41(7):516-24.
  20. Singh A, Sharma K, Venkateswaran V, Trikha A. Pregnancy in thalassemia, anesthetic implication and perioperative management-A narrative review. Journal of Obstetric Anaesthesia and Critical Care. 2021; 11(2):81.
  21. Origa R, Comitini F. Pregnancy in thalassemia. Mediterranean journal of hematology and infectious diseases. 2019; 11(1).
  22. Sharma A, Uppal N, Kukreja S, Kaur M, Kaur S. Screening of thalassemia in pregnant females visiting tertiary hospital in Amritsar. Int J Clin Biochem Res. 2020; 7:226-31.
  23. Abbasinejad F, Shashshahani HJ, Ghalibaf MA. A Comparative Study of Transfusion Reactions in the Thalassemia Patients before and after Implementation of the Hemovigilance System in Yazd Province, Iran. Iranian Journal of Pediatric Hematology & Oncology. 2020; 10(4).
  24. Rezabeigi Davarani E, Mohseni Takaloo F, Vahidnia A, Daneshi S, Rezabeigi Davarani M, Khanjani N, Hushmandi K, Raei M. Epidemiological Investigation of a Twenty-Year Major β-Thalassemia Surveillance in Kerman, Iran. Archives of Hygiene Sciences. 2020; 9(4):265-74.
  25. Yaghobi M, Miri-Moghaddam E, Majid N, Bazi A, Navidian A, Kalkali A. Complications of transfusion-dependent β-thalassemia patients in Sistan and Baluchistan, south-east of Iran. International journal of hematology-oncology and stem cell research. 2017; 11(4):268.
  26. Balgir RS. Prevalence of hemolytic anemia and hemoglobinopathies among the pregnant women attending a tertiary hospital in central India. Thalassemia Reports. 2015; 5(1):4644.
  27. Susheela A, Mondal N, Gupta R, Ganesh K, Brahmankar S, Bhasin S, Gupta G. Effective interventional approach to control anemia in pregnant women. Current Science. 2010:1320-30.
  28. Charoenboon C, Jatavan P, Traisrisilp K, Tongsong T. Pregnancy outcomes among women with beta-thalassemia trait. Archives of gynecology and obstetrics. 2016; 293(4):771-4.
  29. Voskaridou E, Balassopoulou A, Boutou E, Komninaka V, Christoulas D, Dimopoulou M, Delaki EE, Loukopoulos D, Terpos E. Pregnancy in beta-thalassemia intermedia: 20-year experience of a Greek thalassemia center. Eur J Haematol. 2014; 93(6):492-9.
  30. Levy A, Fraser D, Katz M, Mazor M, Sheiner E. Maternal anemia during pregnancy is an independent risk factor for low birthweight and preterm delivery. European journal of obstetrics & gynecology and reproductive biology. 2005; 122(2):182-6.
  31. Nassar AH, Naja M, Cesaretti C, Eprassi B, Cappellini MD, Taher A. Pregnancy outcome in patients with β-thalassemia intermedia at two tertiary care centers, in Beirut and Milan. Haematologica. 2008; 93(10):1586-7.
  32. Zhou Y, Ding Y-L, Zhang L-J, Peng M, Huang J. Direct antiglobulin test-negative autoimmune hemolytic anemia in a patient with β-thalassemia minor during pregnancy: A case report. World Journal of Clinical Cases. 2022; 10(4):1388.
  33. Lee BS, Sathar J, Sivapatham L, Lee LI. Pregnancy outcomes in women with non-transfusion dependent thalassaemia (NTDT): A haematology center experience. Malays J Pathol. 2018; 40(2):149-52.
  34. Taher A, Radwan A, Viprakasit V. When to consider transfusion therapy for patients with non‐transfusion‐dependent thalassaemia. Vox sanguinis. 2015; 108(1):1-10.
  35. Origa R, Piga A, Quarta G, Forni GL, Longo F, Melpignano A, Galanello R. Pregnancy and β-thalassemia: an Italian multicenter experience. haematologica. 2010; 95(3):376-81.
  36. Nassar AH, Usta IM, Rechdan JB, Koussa S, Inati A, Taher AT. Pregnancy in patients with β‐thalassemia intermedia: Outcome of mothers and newborns. American journal of hematology. 2006; 81(7):499-502.
  37. Al-Joudi F, Ali AB, Ramli MBH, Ahmed S, Ismail M. Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan. Asian journal of transfusion science. 2011; 5(1):42.
  38. Nassar AH, Usta IM, Taher AM. Beta-thalassemia intermedia and pregnancy: should we anticoagulate? J Thromb Haemost. 2006; 4(6):1413-4.
  39. Verma A, Jamal S. Thalassemia and Pregnancy: An Update. Jaypee Brothers Medical Publishers (P) Ltd.35.
  40. Sun LB, Sathar J, Sivapatham L, Ing LL. Pregnancy outcomes in women with non-transfusion dependent thalassaemia (NTDT): A hematology center experience. The Malaysian Journal of Pathology. 2018; 40(2):149-52.
  41. Sorrentino F, Maffei L, Caprari P, Cassetta R, Dell'Anna D, Materazzi S, Risoluti R. Pregnancy in thalassemia and sickle cell disease: the experience of an Italian thalassemia center. Frontiers in Molecular Biosciences. 2020; 7:16.
  42. Sookaromdee P, Wiwanitkit V. Pregnancy in thalassemia: Correspondence. Journal of Obstetric Anaesthesia and Critical Care. 2022; 12(1):78.